Treating the few spots where lung cancer has spread
Original title: Local ablative therapy plus systemic treatment versus systemic therapy alone in oligometastatic non-small cell lung cancer: a systematic review and meta-analysis of randomized trials.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This looks across many earlier studies rather than running a new one.
This pools trials already done in people, but it is not yet standard care for everyone.
The short version
When lung cancer has spread to only a few places, treating those spots along with drug treatment helped people live longer.
What was studied. Researchers pooled sixteen randomized trials with 1,343 patients. All had non-small cell lung cancer that had spread to only a few places. Some people got drug treatment alone. Others also got treatment aimed right at the spread spots.
What they found. Across all the trials, adding the spot treatment helped people live longer. It also gave them more time before the cancer grew again. The benefit looked strongest in people with an EGFR gene change who were taking EGFR pills. It did not help people who got immune drugs alone. Serious side effects and lung swelling happened more often with the spot treatment.
What this means, and what it doesn't
What it could mean: If your lung cancer has spread to only a few places, your doctor may bring up treating those spots. It would be added to your usual drug treatment, not used instead of it. Who it helps seems to depend on your gene test results and how many spots you have. Ask your care team whether it fits your situation.
What it doesn't mean: This does not mean the spot treatment helps everyone. It pulls together trials that were already done, so it is not a new trial result. Some groups saw no benefit at all. People who got immune drugs alone did not benefit. People whose cancer had spread to the brain did not see a clear benefit either. The spot treatment also raised the risk of serious side effects. This is not a cure. This study looked at lung cancer, not tumors that start in the brain.
Source: PubMed, October 28, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.